CDC COCA Call: Protecting Infants from Respiratory Syncytial Virus (RSV)

Overview

Respiratory syncytial virus (RSV) is a common respiratory virus that usually causes mild, cold-like symptoms but can also affect the lungs. While most children recover from an RSV infection in a week or two, RSV infection can be dangerous for infants and some young children, causing difficulty breathing, low oxygen levels, and dehydration. RSV is the leading cause of infant hospitalizations in the United States. The Centers for Disease Control and Prevention (CDC) recommends two new immunizations to prevent severe RSV disease in infants and older babies.

During this COCA Call, presenters will give a comprehensive overview of CDC’s new recommendations to prevent severe RSV disease in infants, including clinical guidance and considerations for administering RSV immunizations to infants and pregnant people during weeks 32 through 36 of pregnancy.

Continuing Education Credits Available

Presenters

Sarah Meyer, MD, MPH
Chief Medical Officer
Immunization Services Division
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention

Jefferson Jones, MD, MPH
Co-Lead, ACIP RSV Maternal-Pediatric Work Group
Coronavirus and Other Respiratory Viruses Division
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention